Ouimette Mike

Insider profile

Performance

Overall performance
0.5

Performance over holding periods
0.5
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ouimette Mike's trades of Pliant Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-22 2025-01-22 PrS Proposed sale
97,064
341.80
US$3,085,246
97,064 341.80 US$3,085,246
2025-01-22 2025-01-22 PlS Planned sale
30,560 +22.5%
429.11
US$3,013,608
30,560 +22.5% 429.11 US$3,013,608
2025-01-22 2025-01-17 PlS Planned sale
12,277 -48.2%
485.23
US$3,321,119
12,277 -48.2% 485.23 US$3,321,119
2024-07-12 2024-07-10 PlS Planned sale
7,656 -7.5%
11.56
US$88,503
7,656 -7.5% 11.56 US$88,503
2024-01-19 2024-01-17 PlS Planned sale
5,197 -8.6%
17.23
US$89,544
5,197 -8.6% 17.23 US$89,544
2023-07-21 2023-07-20 PlS Planned sale
4,755 -7.3%
17.55
US$83,450
4,755 -7.3% 17.55 US$83,450
2023-07-20 2023-07-20 PrS Proposed sale
4,755
17.82
US$84,734
4,755 17.82 US$84,734
2023-07-19 2023-07-17 PlS Planned sale
12,778 -16.4%
18.01
US$230,120
12,778 -16.4% 18.01 US$230,120
2023-04-03 2023-04-03 PlS Planned sale
200 -0.4%
27.46
US$5,491
200 -0.4% 27.46 US$5,491
2023-04-03 2023-04-03 PlS Planned sale
2,677 -5.0%
26.74
US$71,575
2,677 -5.0% 26.74 US$71,575
2023-04-03 2023-03-30 PlS Planned sale
4,874 -8.3%
26.52
US$129,263
4,874 -8.3% 26.52 US$129,263
2023-01-25 2023-01-23 PlS Planned sale
20,000 -77.1%
34.19
US$683,878
20,000 -77.1% 34.19 US$683,878
2022-12-23 2022-12-22 PlS Planned sale
2,928 -33.0%
19.38
US$56,731
2,928 -33.0% 19.38 US$56,731
2022-12-21 2022-12-20 S Sale
4,719 -34.7%
19.10
US$90,144
4,719 -34.7% 19.10 US$90,144